Newleos Therapeutics

Newleos Therapeutics

Clinical stage neuroscience firm advancing oral small molecules for anxiety and cognitive disorders.

HQ location
Boston, United States
Launch date
Employees
Enterprise value
$374—561m
Authorizing premium user...